Geoffrey Duyk, Director at Aerie Pharma, holds 23.40K shares in Amyris (Ticker: AMRS), holds 1.70K shares in Aerie Pharma (Ticker: AERI), holds 0.00 shares in Cardiovascular Systems (Ticker: CSII).
Geoffrey Duyk latest transaction was an Uninformative Buy of ―.
What was Geoffrey Duyk's most profitable transaction?
Geoffrey Duyk’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Geoffrey Duyk's role in Aerie Pharma?
Geoffrey Duyk's role in Aerie Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.